PF-03715455

Generic Name
PF-03715455
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C35H34ClN7O3S2
CAS Number
1056164-52-3
Unique Ingredient Identifier
0TJ631J0KP
Background

PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive, and Chronic Obstructive Pulmonary Disease (COPD).

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease

First Posted Date
2015-02-19
Last Posted Date
2016-07-06
Lead Sponsor
Pfizer
Target Recruit Count
13
Registration Number
NCT02366637
Locations
πŸ‡¬πŸ‡§

Nottingham University Hospital NHS Trust, Nottingham, Nottinghamshire, United Kingdom

πŸ‡¬πŸ‡§

University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

πŸ‡¬πŸ‡§

Heart of England NHS Foundation Trust, Birmingham, United Kingdom

and more 2 locations

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Phase 2
Terminated
Conditions
Asthma
Interventions
Drug: Placebo
Drug: PF-03715455
First Posted Date
2014-08-18
Last Posted Date
2019-06-12
Lead Sponsor
Pfizer
Target Recruit Count
51
Registration Number
NCT02219048
Locations
πŸ‡ΊπŸ‡Έ

Clinical Research Center of Alabama, Birmingham, Alabama, United States

πŸ‡ΊπŸ‡Έ

Pulmonary Associates, Pa, Phoenix, Arizona, United States

πŸ‡ΊπŸ‡Έ

Little Rock Allergy & Asthma Clinical Research Center, Little Rock, Arkansas, United States

and more 25 locations

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

First Posted Date
2011-03-15
Last Posted Date
2012-02-02
Lead Sponsor
Pfizer
Target Recruit Count
39
Registration Number
NCT01314885
Locations
πŸ‡¬πŸ‡§

Pfizer Investigational Site, Manchester, United Kingdom

Multiple Dose Healthy Volunteer Study of PF-03715455.

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
Drug: PF-03715455
First Posted Date
2010-08-23
Last Posted Date
2011-01-12
Lead Sponsor
Pfizer
Target Recruit Count
36
Registration Number
NCT01186757
Locations
πŸ‡ΈπŸ‡¬

Pfizer Investigational Site, Singapore, Singapore

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy